Liisa Bayko analyst EVERCORE

Currently out of the existing stock ratings of Liisa Bayko, 95 are a BUY (90.48%), 10 are a HOLD (9.52%).

Liisa Bayko

Work Performance Price Targets & Ratings Chart

Analyst Liisa Bayko works at EVERCORE with a stock forecast success ratio of 40.96% fulfilled within 203.76 days on average.

Liisa Bayko’s has documented 230 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ANTX, AN2 Therapeutics at 12-Feb-2024.

Wall Street Analyst Liisa Bayko

Analyst best performing recommendations are on EDIT (EDITAS MEDICINE).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 1/9/2018. The price target of $60 was fulfilled within 3 days with a profit of $3.85 (6.86%) receiving and performance score of 22.86.

Average potential price target upside

ABUS Arbutus Biopharma Corp AIMT Aimmune Therapeutics BCRX BioCryst Pharmaceuticals CRSP Crispr Therapeutics AG ENTA Enanta Pharmaceuticals ICPT Intercept Pharmaceuticals INSM Insmed KNSA Kiniksa Pharmaceuticals Ltd RARE Ultragenyx SRPT Sarepta Therapeutics ACHN Achillion Pharmaceuticals EDIT Editas Medicine INCY yte MDGL Madrigal Pharmaceuticals TVTX Travere Therapeutics VRTX Vertex Pharmaceuticals PRQR ProQR Therapeutics BV AKRO Akero Therapeutics ALT Altimmune AURA Aura Biosciences CNCE Concert Pharmaceuticals CRBP Corbus Pharmaceuticals RTRX Travere Therapeutics VERA Vera Therapeutics ANTX AN2 Therapeutics

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$0.91 (29.45%)


13 days ago

0/5 (0%)

$1 (33.33%)



$0.91 (29.45%)


1 months 16 days ago

1/8 (12.5%)

$1.21 (43.37%)




$1.91 (61.81%)


1 months 16 days ago

0/13 (0%)

$2.21 (79.21%)



$2.08 (71.23%)

2 years 2 months 15 days ago

0/1 (0%)

$2.11 (73.01%)



2 years 9 months 20 days ago

0/4 (0%)

$3.7 (112.12%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Liisa Bayko is most bullish on?

Potential upside of $33.78 has been obtained for VRTX (VERTEX PHARMACEUTICALS)

Which stock is Liisa Bayko is most reserved on?

Potential downside of $3.99 has been obtained for ANTX (AN2 THERAPEUTICS)

What Year was the first public recommendation made by Liisa Bayko?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?